Metformin and Esomeprazole in Preterm Pre-eclampsia
Status:
TERMINATED
Trial end date:
2025-05-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to better understand diagnosis and treatment of preterm preeclampsia. Currently, there are limited laboratory tests that can be used to diagnosis preeclampsia. Additionally, there are few treatments for this condition. This clinical trial will explore treatment options, Metformin and Esomeprazole, as well as serum markers that could improve the diagnosis and treatment of preterm preeclampsia.